These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical and histopathologic features of 8 patients with microscopic polyangiitis including two with a slowly progressive clinical course. Kawakami T; Kawanabe T; Saito C; Kannari M; Mizoguchi M; Nagafuchi H; Okazaki T; Ozaki S; Kimura K; Soma Y J Am Acad Dermatol; 2007 Nov; 57(5):840-8. PubMed ID: 17939936 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of ANCA associated systemic necrotizing vasculitides]. Guillevin L Bull Acad Natl Med; 2008; 192(6):1175-87; discussion 1188. PubMed ID: 19235481 [TBL] [Abstract][Full Text] [Related]
25. Review article: Progress of treatment in ANCA-associated vasculitis. Jayne D Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843 [TBL] [Abstract][Full Text] [Related]
27. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA Ann Rheum Dis; 2006 Nov; 65(11):1484-9. PubMed ID: 16504995 [TBL] [Abstract][Full Text] [Related]
28. Severe microscopic polyangiitis with unilateral vocal cord paralysis as initial manifestation. Flores-Suárez LF; Alba MA; Tona G Colomb Med (Cali); 2017 Mar; 48(1):32-34. PubMed ID: 28559644 [TBL] [Abstract][Full Text] [Related]
33. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482 [TBL] [Abstract][Full Text] [Related]
34. Acute orbital inflammatory syndrome secondary to an ANCA-positive small-vessel vasculitis: a case report and review of the literature. Maleki B; Valenzuela AA; Huang WY; Heathcote JG Orbit; 2012 Oct; 31(5):321-3. PubMed ID: 22642696 [TBL] [Abstract][Full Text] [Related]
35. Vasculitis mimics: cocaine-induced midline destructive lesions. Perez Alamino R; Espinoza LR Am J Med Sci; 2013 Nov; 346(5):430-1. PubMed ID: 23811575 [TBL] [Abstract][Full Text] [Related]
36. Wegener granulomatosis: a case report and update. Mubashir E; Ahmed MM; Hayat S; Latif S; Heldmann M; Berney SM South Med J; 2006 Sep; 99(9):977-88. PubMed ID: 17004532 [TBL] [Abstract][Full Text] [Related]
37. Microscopic polyangiitis: clinical aspects and treatment. Lhote F; Cohen P; Généreau T; Gayraud M; Guillevin L Ann Med Interne (Paris); 1996; 147(3):165-77. PubMed ID: 8796093 [TBL] [Abstract][Full Text] [Related]
38. From fibrosis to diagnosis: a paediatric case of microscopic polyangiitis and review of the literature. Roszkiewicz J; Smolewska E Rheumatol Int; 2018 Apr; 38(4):683-687. PubMed ID: 29294176 [TBL] [Abstract][Full Text] [Related]
39. Successful Immunosuppressive Treatment of Mixed Connective Tissue Disease Complicated by Microscopic Polyangiitis. Sato S; Yashiro M; Matsuoka N; Uematsu M; Asano T; Kobayashi H; Watanabe H; Ohira H Tohoku J Exp Med; 2016 Jun; 239(2):111-6. PubMed ID: 27238624 [TBL] [Abstract][Full Text] [Related]
40. Microscopic polyangiitis involving the breast. Devinck M; Vander Cruyssen B; Lambein K; De Keyser F; Praet M; Brusselle G Acta Clin Belg; 2011; 66(2):139-41. PubMed ID: 21630614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]